Claritev Corporation (CTEV)
Claritev Corporation (CTEV) Stock Price, Analysis & Data
| Bid | n/a |
| Market Cap | 618.41M |
| Revenue (ttm) | 994.67M |
| Net Income (ttm) | -283.11M |
| Beta | 0.79 |
| EPS (ttm) | -17 |
| PE Ratio (ttm) | n/a |
| Forward PE | 4.98 |
| P/B (ttm) | -2.10 |
| P/S (ttm) | 0.62 |
| Earnings Date | Nov 8, 2022 |
| Ask | 56.7 |
| Volume | 92,211 |
| Avg. Volume (20D) | 126,879 |
| Open | 35.02 |
| Previous Close | 35.35 |
| Day's Range | 34.58 - 36.24 |
| 52-Week Range | 11.50 - 74.07 |
| Analyst | Buy |
| Price Target | 43.5 (22.19%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CTEV
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build ...
Financial Performance
In 2025, Claritev's revenue was 965.41M, an increase of 3.74% compared to the previous year's 930.62M. Earnings were -284.28M, a decrease of -82.73%.
Financial StatementsAnalyst Forecast
According to 6 analyst ratings, the average rating for CTEV stock is "Buy". The 12-month stock price forecast is 43.5, which is upside of 22.19% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
